Clinical Trial Update: Efficacy, Safety, and Tolerability of Remlarsen (MRG-201) Following Intradermal Injection in Subjects With a History of Keloids [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy, safety, and tolerability of intradermal Remlarsen (MRG-201) in subjects with a history of keloids has been completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloid

Drugs mentioned

• Remlarsen (MRG-201)

Snippet

Sponsor: miRagen Therapeutics, Inc. | Conditions: Keloid | Phase 2 | Status: COMPLETED | Results posted: 2021-07-19